These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31827918)

  • 1. Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients.
    Lee DW; Jung M; Wang HW; Khan Z; Pinton P
    Int J Hypertens; 2019; 2019():9516279. PubMed ID: 31827918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy.
    Ma J; Wang XY; Hu ZD; Zhou ZR; Schoenhagen P; Wang H
    J Thorac Dis; 2015 Dec; 7(12):2243-52. PubMed ID: 26793346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
    Ram CV
    Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension.
    Rakugi H; Shimizu K; Nishiyama Y; Sano Y; Umeda Y
    Blood Press; 2018 Jun; 27(3):125-133. PubMed ID: 29235365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan　- Systematic Review and Network Meta-Analysis.
    Nakajima T; Oh A; Saita S; Yoshida T; Ohishi M; Nishigaki N
    Circ Rep; 2020 Sep; 2(10):576-586. PubMed ID: 33693183
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
    de la Sierra A; Barrios V
    Adv Ther; 2012 May; 29(5):401-15. PubMed ID: 22610686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
    Redon J; Pichler G;
    Am J Hypertens; 2016 Sep; 29(9):1055-62. PubMed ID: 27220840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R; Weir MR
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.
    He T; Liu X; Li Y; Liu XY; Wu QY; Liu ML; Yuan H
    J Hum Hypertens; 2017 Feb; 31(2):79-88. PubMed ID: 27511478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial.
    Dash A; Meher BR; Padhy BM; Mohanty RR; Tripathy A
    Cureus; 2023 Mar; 15(3):e35865. PubMed ID: 37033509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic outcomes associated with amlodipine/renin-angiotensin system blocker combinations.
    Ferrario CM; Panjabi S; Buzinec P; Swindle JP
    Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):27-39. PubMed ID: 23328188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension.
    Akioyamen L; Levine M; Sherifali D; O'Reilly D; Frankfurter C; Pullenayegum E; Goeree R; Tsoi B
    J Am Soc Hypertens; 2016 Jan; 10(1):55-69.e1. PubMed ID: 26684588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.